{"id":"https://openalex.org/W4281631911","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.1025","title":"The mutational profile of ER-, PR+, HER2- metastatic breast cancer.","display_name":"The mutational profile of ER-, PR+, HER2- metastatic breast cancer.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281631911","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.1025"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.1025","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.1025","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.1025","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114043678","display_name":"Neal A. Fischbach","orcid":"https://orcid.org/0000-0002-5416-9114","observed_orcids":["https://orcid.org/0000-0002-5416-9114"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal A. Fischbach","raw_affiliation_strings":["Yale Cancer Center, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, New Haven, CT;","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034444686","display_name":"Richard S.P. Huang","orcid":"https://orcid.org/0000-0001-8395-5168","observed_orcids":["https://orcid.org/0000-0001-8395-5168"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard S.P. Huang","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086903918","display_name":"Maryam B. Lustberg","orcid":"https://orcid.org/0000-0001-8559-5645","observed_orcids":["https://orcid.org/0000-0001-8559-5645"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryam B. Lustberg","raw_affiliation_strings":["Yale Cancer Center, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, New Haven, CT;","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091324080","display_name":"Maureen Pelletier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maureen Pelletier","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021113979","display_name":"Lajos Pusztai","orcid":"https://orcid.org/0000-0001-9632-6686","observed_orcids":["https://orcid.org/0000-0001-9632-6686"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lajos Pusztai","raw_affiliation_strings":["Yale School of Medicine, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale School of Medicine, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020119624","display_name":"Smruthy Sivakumar","orcid":"https://orcid.org/0000-0001-7790-5615","observed_orcids":["https://orcid.org/0000-0001-7790-5615"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smruthy Sivakumar","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067701996","display_name":"Ethan S. Sokol","orcid":"https://orcid.org/0000-0002-5480-8473","observed_orcids":["https://orcid.org/0000-0002-5480-8473","https://orcid.org/0000-0002-2988-0537"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan Sokol","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088559019","display_name":"Jeffrey S. Ross","orcid":"https://orcid.org/0000-0001-8494-2596","observed_orcids":["https://orcid.org/0000-0001-8494-2596"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Ross","raw_affiliation_strings":["Foundation Medicine, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030770357","display_name":"Mia Alyce Levy","orcid":"https://orcid.org/0000-0002-5944-2730","observed_orcids":["https://orcid.org/0000-0002-5944-2730"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mia Alyce Levy","raw_affiliation_strings":["Foundation Medicine Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"1025","last_page":"1025"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5019999742507935,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5019999742507935,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.28049999475479126,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.17430000007152557,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/mutational-landscape","display_name":"mutational landscape","score":0.9020000100135803},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7129999995231628},{"id":"https://openalex.org/keywords/genomic-profiling","display_name":"genomic profiling","score":0.6050000190734863},{"id":"https://openalex.org/keywords/tp53-alterations","display_name":"TP53 alterations","score":0.8080000281333923},{"id":"https://openalex.org/keywords/rb1-alterations","display_name":"RB1 alterations","score":0.8529999852180481},{"id":"https://openalex.org/keywords/egfr-alterations","display_name":"EGFR alterations","score":0.5870000123977661},{"id":"https://openalex.org/keywords/met-alterations","display_name":"MET alterations","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pten-alterations","display_name":"PTEN alterations","score":0.8069999814033508},{"id":"https://openalex.org/keywords/immunotherapy-biomarkers","display_name":"immunotherapy biomarkers","score":0.7450000047683716},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.4869999885559082},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7859718799591064},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.7666990160942078},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7079813480377197},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6874544024467468},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.6246365904808044},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.5981675386428833},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5324640870094299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5131776928901672},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.47471559047698975},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4459962844848633},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44376495480537415},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4396759271621704},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.15711790323257446},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1180034875869751},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.1025","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.1025","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.1025","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7202114861","https://openalex.org/W4397006885","https://openalex.org/W4389303409","https://openalex.org/W817891140","https://openalex.org/W4396587355","https://openalex.org/W2904794101","https://openalex.org/W2791303954","https://openalex.org/W2911710003","https://openalex.org/W4280527343","https://openalex.org/W2589778701"],"abstract_inverted_index":{"1025":[0],"Background:":[1],"ER-PR+Her2-":[2,233,266,305,327],"breast":[3,15,37,76,87,268,276],"cancer":[4,38,269],"is":[5,45],"a":[6,69,198,229,285],"rare":[7,143,294],"subtype":[8],"occurring":[9],"at":[10,228,323],"approximately":[11],"1%":[12],"of":[13,18,42,68,73,162,170,178,201,296],"all":[14],"carcinomas.":[16],"Most":[17],"these":[19,43],"cancers":[20,77,88,234,328],"behave":[21],"in":[22,119,153,183,206,232,307,326],"an":[23],"aggressive":[24],"fashion":[25],"with":[26,335],"limited":[27],"benefit":[28],"from":[29,107],"anti":[30],"estrogen":[31],"therapy,":[32,54],"similar":[33,136,150,182,257],"to":[34,52,63,80,90,151,243,288],"triple":[35],"negative":[36],"(TNBC).":[39],"Better":[40],"characterization":[41],"tumors":[44,141,158],"needed":[46],"for":[47,57,93,265,292,310],"predicting":[48],"clinical":[49,58,308],"behavior,":[50],"response":[51],"endocrine":[53],"and":[55,78,102,116,148,164,167,173,186,189,192,222,239,253,319],"eligibility":[56],"trials.":[59],"Here":[60],"we":[61,302],"sought":[62],"evaluate":[64],"the":[65,184,207,215,244,259],"mutational":[66,263],"profile":[67,264],"well":[70],"curated":[71],"set":[72],"ER-PR+HER2-":[74,140,185,208],"metastatic":[75,267],"compare":[79],"other":[81,216,245,330],"receptor":[82],"phenotypes.":[83],"Methods:":[84],"2049":[85],"consecutive":[86],"submitted":[89,108],"Foundation":[91],"Medicine":[92],"comprehensive":[94],"genomic":[95,155],"profiling":[96,282],"(CGP)":[97],"were":[98,105,122,135,142,204,225,256],"included.":[99],"ER,":[100,114],"PR":[101,115],"HER2":[103,117],"expression":[104],"abstracted":[106],"pathology":[109,120],"reports.":[110],"Cases":[111],"without":[112],"complete":[113],"information":[118],"reports":[121],"excluded.":[123],"CGP":[124],"was":[125,181],"performed":[126],"as":[127],"previously":[128],"described":[129],"(Frampton,":[130],"2013).":[131],"Results:":[132],"Patient":[133],"ages":[134],"across":[137],"subgroups.":[138],"Generally,":[139],"(n":[144],"=":[145],"23,":[146],"1.1%)":[147],"most":[149],"TNBC":[152,195,273],"their":[154],"profiles.":[156],"These":[157,278],"harbored":[159],"high":[160,199],"rates":[161,169],"TP53":[163],"BRCA1":[165],"alterations":[166,203,224],"low":[168],"PIK3CA,":[171],"ESR1,":[172],"CDH1":[174],"alterations.":[175],"Genomic":[176],"loss":[177],"heterozygosity":[179],"(gLOH)":[180],"ER+PR+HER2-subtypes":[187],"(8.18%":[188],"8.66%":[190],"respectively),":[191],"lower":[193],"than":[194,214,274,329],"(17.19%).":[196],"Notably,":[197],"rate":[200],"RB1":[202],"identified":[205],"patients":[209,306],"(13%,":[210],"3/23),":[211],"numerically":[212],"higher":[213,230,324],"subtypes.":[217,246],"EGFR,":[218],"MET,":[219],"PTEN,":[220,317],"CDKN2A":[221],"KRAS":[223],"also":[226],"observed":[227],"frequency":[231,325],"(8.7,":[235],"4.2,":[236],"39.1,":[237],"13.0":[238],"13.0%":[240],"respectively)":[241],"relative":[242],"IO":[247],"drug":[248],"biomarkers":[249],"including":[250,304,314],"MSI,":[251],"TMB":[252],"PD-L1":[254],"IHC":[255],"among":[258],"groups.":[260],"Conclusions:":[261],"The":[262],"more":[270],"closely":[271],"resembles":[272],"ER+":[275],"cancer.":[277],"data":[279],"suggest":[280],"molecular":[281,300],"may":[283],"be":[284],"useful":[286],"adjunct":[287],"optimize":[289],"treatment":[290],"strategies":[291],"this":[293],"subset":[295],"cancers.":[297],"Based":[298],"on":[299],"characteristics,":[301],"recommend":[303],"trials":[309],"TNBC.":[311],"Finally,":[312],"genes":[313],"RB1,":[315],"CKDN2A,":[316],"EGFR":[318],"MET":[320],"are":[321],"mutated":[322],"subsets,":[331],"suggesting":[332],"unique":[333],"biology":[334],"potential":[336],"therapeutic":[337],"implications.":[338],"[Table:":[339],"see":[340],"text]":[341]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2022-06-13T00:00:00"}